The Medicare Payment Advisory Commission will vote in April on a proposal to recommend enactment of private third party negotiation model to control the cost of physician administered drugs under Part B.
MedPAC discussed a proposal for a so-called Drug Value Program (DVP) at its March 2 meeting. The commission’s role is to make recommendations to Congress – ideas Congress...
In many respects, the DVP is a revival of the Competitive Acquisition (CAP) program, updated to move it closer to the Part D outpatient drug model. MedPAC principal policy analyst...